Consequence of cryptorchidism: Relationship to etiology and treatment

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Increased risk of infertility and testicular tumors after cryptorchidism is the basis for treatment. Over the past few decades the recommended age of therapy has become younger and younger, so that currently therapy is recommended before 2 years of age and as early as 6 months. Evidence indicates that treatment before 10 years of age reduces the incidence of testicular tumors among men who formerly had unilateral cryptorchidism to that of men without a history of cryptorchidism. However, the effect of the age of treatment among the bilateral group is unknown. Infertility after bilateral cryptorchidism is about six times greater than that of the general population, affecting about half of patients; it appears to be only two times greater among the unilateral group, affecting about 10% of patients. To date no effect of age of therapy has been demonstrated, although current studies have not been able to consider the underlying cause of the cryptorchidism. Data are not yet available to determine whether pretreatment testicular location or size is related to subsequent fertility. The current recommendation for treatment within the first 2 years of life is based on the progressive degeneration of germ cells within the persistently cryptorchid testis after the first year of life. This recommendation should stand, even though some testes may be i r r e t r i e v a b l y damaged before such early therapy, and others may suffer minimal or no detrimental effect after delayed treatment. Future information may identify specific causes of cryptorchidism and, hence, determination of which patients will benefit from early therapy.

Original languageEnglish (US)
Pages (from-to)232-236
Number of pages5
JournalCurrent Problems in Pediatrics
Volume25
Issue number7
DOIs
StatePublished - Jan 1 1995

Fingerprint

Cryptorchidism
Testicular Neoplasms
Therapeutics
Secondary Prevention
Infertility
Testis
Germ Cells
Fertility
Incidence

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{18e03311a6604a87a986772c44e95c0a,
title = "Consequence of cryptorchidism: Relationship to etiology and treatment",
abstract = "Increased risk of infertility and testicular tumors after cryptorchidism is the basis for treatment. Over the past few decades the recommended age of therapy has become younger and younger, so that currently therapy is recommended before 2 years of age and as early as 6 months. Evidence indicates that treatment before 10 years of age reduces the incidence of testicular tumors among men who formerly had unilateral cryptorchidism to that of men without a history of cryptorchidism. However, the effect of the age of treatment among the bilateral group is unknown. Infertility after bilateral cryptorchidism is about six times greater than that of the general population, affecting about half of patients; it appears to be only two times greater among the unilateral group, affecting about 10{\%} of patients. To date no effect of age of therapy has been demonstrated, although current studies have not been able to consider the underlying cause of the cryptorchidism. Data are not yet available to determine whether pretreatment testicular location or size is related to subsequent fertility. The current recommendation for treatment within the first 2 years of life is based on the progressive degeneration of germ cells within the persistently cryptorchid testis after the first year of life. This recommendation should stand, even though some testes may be i r r e t r i e v a b l y damaged before such early therapy, and others may suffer minimal or no detrimental effect after delayed treatment. Future information may identify specific causes of cryptorchidism and, hence, determination of which patients will benefit from early therapy.",
author = "Peter Lee",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/S0045-9380(06)80037-X",
language = "English (US)",
volume = "25",
pages = "232--236",
journal = "Current Problems in Pediatric and Adolescent Health Care",
issn = "1538-5442",
publisher = "Mosby Inc.",
number = "7",

}

Consequence of cryptorchidism : Relationship to etiology and treatment. / Lee, Peter.

In: Current Problems in Pediatrics, Vol. 25, No. 7, 01.01.1995, p. 232-236.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Consequence of cryptorchidism

T2 - Relationship to etiology and treatment

AU - Lee, Peter

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Increased risk of infertility and testicular tumors after cryptorchidism is the basis for treatment. Over the past few decades the recommended age of therapy has become younger and younger, so that currently therapy is recommended before 2 years of age and as early as 6 months. Evidence indicates that treatment before 10 years of age reduces the incidence of testicular tumors among men who formerly had unilateral cryptorchidism to that of men without a history of cryptorchidism. However, the effect of the age of treatment among the bilateral group is unknown. Infertility after bilateral cryptorchidism is about six times greater than that of the general population, affecting about half of patients; it appears to be only two times greater among the unilateral group, affecting about 10% of patients. To date no effect of age of therapy has been demonstrated, although current studies have not been able to consider the underlying cause of the cryptorchidism. Data are not yet available to determine whether pretreatment testicular location or size is related to subsequent fertility. The current recommendation for treatment within the first 2 years of life is based on the progressive degeneration of germ cells within the persistently cryptorchid testis after the first year of life. This recommendation should stand, even though some testes may be i r r e t r i e v a b l y damaged before such early therapy, and others may suffer minimal or no detrimental effect after delayed treatment. Future information may identify specific causes of cryptorchidism and, hence, determination of which patients will benefit from early therapy.

AB - Increased risk of infertility and testicular tumors after cryptorchidism is the basis for treatment. Over the past few decades the recommended age of therapy has become younger and younger, so that currently therapy is recommended before 2 years of age and as early as 6 months. Evidence indicates that treatment before 10 years of age reduces the incidence of testicular tumors among men who formerly had unilateral cryptorchidism to that of men without a history of cryptorchidism. However, the effect of the age of treatment among the bilateral group is unknown. Infertility after bilateral cryptorchidism is about six times greater than that of the general population, affecting about half of patients; it appears to be only two times greater among the unilateral group, affecting about 10% of patients. To date no effect of age of therapy has been demonstrated, although current studies have not been able to consider the underlying cause of the cryptorchidism. Data are not yet available to determine whether pretreatment testicular location or size is related to subsequent fertility. The current recommendation for treatment within the first 2 years of life is based on the progressive degeneration of germ cells within the persistently cryptorchid testis after the first year of life. This recommendation should stand, even though some testes may be i r r e t r i e v a b l y damaged before such early therapy, and others may suffer minimal or no detrimental effect after delayed treatment. Future information may identify specific causes of cryptorchidism and, hence, determination of which patients will benefit from early therapy.

UR - http://www.scopus.com/inward/record.url?scp=0029348082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029348082&partnerID=8YFLogxK

U2 - 10.1016/S0045-9380(06)80037-X

DO - 10.1016/S0045-9380(06)80037-X

M3 - Article

C2 - 8521719

AN - SCOPUS:0029348082

VL - 25

SP - 232

EP - 236

JO - Current Problems in Pediatric and Adolescent Health Care

JF - Current Problems in Pediatric and Adolescent Health Care

SN - 1538-5442

IS - 7

ER -